The action of ERK1 and ERK2 activity on the nuclear substrates requires crossing the nuclear envelope and the localization of phospho-ERK into the nucleus. The nucleo-cytoplasmic trafficking of ERK is therefore crucial for the correct functioning of the pathway. Indeed, this step is necessary for the correct control of gene expression by growth-factors, for morphological transformation of fibroblasts and for neurite extension in PC12. Furthermore, disruption of ERK2 localization in the nucleus severely affects the transduction of ERK2 signaling. This process has now been observed and quantitatively measured by expressing fluorescently tagged ERK1 and ERK2. These experiments provide important insight on the operation of these signaling modules and have revealed an hitherto unknown functional difference between ERK1 and ERK2.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-1-60761-795-2_17 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ERK1/2 gene expression and hypomethylation of Alu and LINE1 elements in patients with type 2 diabetes with and without cataract: Impact of hyperglycemia-induced oxidative stress.
J Diabetes Investig
January 2025
Department of Medical Sciences, Shahid Beheshti University, Tehran, Iran.
Aims: This study aimed to delineate the effect of hyperglycemia on the Alu/LINE-1 hypomethylation and in ERK1/2 genes expression in type 2 diabetes with and without cataract.
Methods: This study included 58 diabetic patients without cataracts, 50 diabetic patients with cataracts, and 36 healthy controls. After DNA extraction and bisulfite treatment, LINE-1 and Alu methylation levels were assessed using Real-time MSP.
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Nat Med
January 2025
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
The MEK inhibitor selumetinib induces objective responses and provides clinical benefit in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs). To evaluate whether similar outcomes were possible in adult patients, in whom PN growth is generally slower than in pediatric patients, we conducted an open-label phase 2 study of selumetinib in adults with NF1 PNs. The study was designed to evaluate objective response rate (primary objective), tumor volumetric responses, patient-reported outcomes and pharmacodynamic effects in PN biopsies.
View Article and Find Full Text PDFExploration of drug repurposing for Mpox outbreaks targeting gene signatures and host-pathogen interactions.
Sci Rep
November 2024
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Article Synopsis
- Monkeypox (Mpox) is increasingly recognized as a public health issue, and this study uses multi-omics approaches to find therapeutic targets and drug repurposing opportunities to understand its molecular mechanisms.
- Researchers created a host-pathogen interaction network and identified 55 differentially expressed genes related to Mpox, pinpointing 16 potential drug targets that include both proviral and antiviral genes involved in critical signaling pathways.
- Promising FDA-approved drug candidates, such as kinase inhibitors and Niclosamide, were identified, aiming to enhance treatment strategies and further the understanding of Mpox's pathology.
Transfer RNA-derived fragment production in calves challenged with or co-infected with bovine viral diarrhea virus and in several tissues and blood.
Front Vet Sci
November 2024
Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, United States.
Understanding the molecular mechanisms underlying immune response can allow informed decisions in drug or vaccine development, and aid in the identification of biomarkers to predict exposure or evaluate treatment efficacy. The objective of this study was to identify differentially expressed transfer RNA-derived fragments (tRFs) in calves challenged with () or co-infected with and bovine viral diarrhea virus (BVDV). Serum, white blood cells (WBC), liver, mesenteric lymph node (MLN), tracheal-bronchial lymph node (TBLN), spleen, and thymus were collected from Control ( = 2), (MB; = 3), and co-infected (Dual; = 3) animals, and small RNAs extracted for sequencing.
View Article and Find Full Text PDFThe MAPK/ERK signaling pathway involved in Raddeanin A induces apoptosis via the mitochondrial pathway and G2 phase arrest in multiple myeloma.
Sci Rep
November 2024
School of Basic Medicine, Chengdu Medical College, Chengdu, 610500, China.
Article Synopsis
- Multiple myeloma (MM) is a type of blood cancer marked by excessive production of plasma cells that release antibodies, and current research on treatments like Raddeanin A (RA) focuses mainly on solid tumors, leaving a gap in understanding its effects on MM specifically.
- RA, derived from Anemone raddeana regel, shows promising anti-tumor effects, and this study explores how it may inhibit MM cell growth through network pharmacology and experimental methods, revealing significant interactions with the MAPK signaling pathway.
- Experimental results demonstrate that RA effectively slows MM cell proliferation, induces apoptosis, alters mitochondrial function, and impacts the expression of key proteins involved in cell growth and survival, suggesting a powerful potential for RA as a treatment for multiple my
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!